Christopher Mutz, Head of Rare Disease at ANI Pharmaceuticals ($ANIP), sold about $1.88 million worth of company shares across seven open market transactions in the last year. His most recent sale occurred on March 13, 2026. These sales rank 3,623rd among 11,678 individual insiders in our database, where the average is $8.6 million over about 6.4 transactions. Mutz made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 13, 2026 | ANI PHARMACEUTICALS INC | $ANIP | Mutz Christopher | HEAD OF RARE DISEASE | S | Common Stock | 3162 | $71.64 | 91,309.0000 | 23,076,000 | 3.35% | 0.01% |
| March 9, 2026 | ANI PHARMACEUTICALS INC | $ANIP | Mutz Christopher | HEAD OF RARE DISEASE | S | Common Stock | 3602 | $74.18 | 94,471.0000 | 23,076,000 | 3.67% | 0.02% |
| March 7, 2026 | ANI PHARMACEUTICALS INC | $ANIP | Mutz Christopher | HEAD OF RARE DISEASE | F | Common Stock | 3314 | $74.04 | 98,073.0000 | 23,076,000 | 3.27% | 0.01% |
| March 6, 2026 | ANI PHARMACEUTICALS INC | $ANIP | Mutz Christopher | HEAD OF RARE DISEASE | S | Common Stock | 2121 | $74.22 | 101,387.0000 | 23,076,000 | 2.05% | 0.01% |
| March 2, 2026 | ANI PHARMACEUTICALS INC | $ANIP | Mutz Christopher | HEAD OF RARE DISEASE | S | Common Stock | 417 | $74.00 | 103,508.0000 | 23,076,000 | 0.40% | 0.00% |
| Feb. 26, 2026 | ANI PHARMACEUTICALS INC | $ANIP | Mutz Christopher | HEAD OF RARE DISEASE | A | Common Stock | 21306 | $77.15 | 106,146.0000 | 23,076,000 | 25.11% | 0.09% |
| Feb. 28, 2026 | ANI PHARMACEUTICALS INC | $ANIP | Mutz Christopher | HEAD OF RARE DISEASE | F | Common Stock | 2221 | $73.90 | 103,925.0000 | 23,076,000 | 2.09% | 0.01% |
| Feb. 20, 2026 | ANI PHARMACEUTICALS INC | $ANIP | Mutz Christopher | HEAD OF RARE DISEASE | S | Common Stock | 5323 | $78.02 | 84,840.0000 | 23,076,000 | 5.90% | 0.02% |
| Feb. 12, 2026 | ANI PHARMACEUTICALS INC | $ANIP | Mutz Christopher | HEAD OF RARE DISEASE | F | Common Stock | 3173 | $76.70 | 99,598.0000 | 23,076,000 | 3.09% | 0.01% |
| Feb. 14, 2026 | ANI PHARMACEUTICALS INC | $ANIP | Mutz Christopher | HEAD OF RARE DISEASE | F | Common Stock | 2403 | $77.36 | 90,163.0000 | 23,076,000 | 2.60% | 0.01% |
| Feb. 12, 2026 | ANI PHARMACEUTICALS INC | $ANIP | Mutz Christopher | HEAD OF RARE DISEASE | S | Common Stock | 7032 | $76.55 | 92,566.0000 | 23,076,000 | 7.06% | 0.03% |
| Feb. 11, 2026 | ANI PHARMACEUTICALS INC | $ANIP | Mutz Christopher | HEAD OF RARE DISEASE | F | Common Stock | 4546 | $76.25 | 102,771.0000 | 23,076,000 | 4.24% | 0.02% |
| May 14, 2025 | ANI PHARMACEUTICALS INC | $ANIP | Mutz Christopher | HEAD OF RARE DISEASE | S | Common Stock | 4000 | $60.45 | 107,317.0000 | 21,538,000 | 3.59% | 0.02% |
| March 7, 2025 | ANI PHARMACEUTICALS INC | $ANIP | Mutz Christopher | HEAD OF RARE DISEASE | F | Common Stock | 2874 | $60.62 | 111,317.0000 | 21,538,000 | 2.52% | 0.01% |
| Feb. 28, 2025 | ANI PHARMACEUTICALS INC | $ANIP | Mutz Christopher | HEAD OF RARE DISEASE | F | Common Stock | 1275 | $61.89 | 114,191.0000 | 21,538,000 | 1.10% | 0.01% |
| Feb. 12, 2025 | ANI PHARMACEUTICALS INC | $ANIP | Mutz Christopher | HEAD OF RARE DISEASE | A | Common Stock | 24808 | $0.00 | 101,585.0000 | 21,538,000 | 32.31% | 0.12% |
| Feb. 15, 2025 | ANI PHARMACEUTICALS INC | $ANIP | Mutz Christopher | HEAD OF RARE DISEASE | F | Common Stock | 1184 | $58.92 | 115,466.0000 | 21,538,000 | 1.02% | 0.01% |
| Feb. 12, 2025 | ANI PHARMACEUTICALS INC | $ANIP | Mutz Christopher | HEAD OF RARE DISEASE | A | Common Stock | 16538 | $0.00 | 118,123.0000 | 21,538,000 | 16.28% | 0.08% |
| Feb. 14, 2025 | ANI PHARMACEUTICALS INC | $ANIP | Mutz Christopher | HEAD OF RARE DISEASE | F | Common Stock | 1473 | $58.92 | 116,650.0000 | 21,538,000 | 1.25% | 0.01% |
| Nov. 15, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Mutz Christopher | HEAD OF RARE DISEASE | S | Common Stock | 6500 | $57.70 | 76,777.0000 | 21,494,000 | 7.81% | 0.03% |
| May 21, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Mutz Christopher | HEAD OF RARE DISEASE | S | Common Stock | 2000 | $61.61 | 83,277.0000 | 20,731,000 | 2.35% | 0.01% |
| March 7, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Mutz Christopher | HEAD OF RARE DISEASE | F | Common Stock | 2110 | $66.71 | 85,277.0000 | 20,731,000 | 2.41% | 0.01% |
| March 5, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Mutz Christopher | HEAD OF RARE DISEASE | S | Common Stock | 5000 | $66.00 | 87,387.0000 | 20,731,000 | 5.41% | 0.02% |
| Feb. 29, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Mutz Christopher | HEAD OF RARE DISEASE | F | Common Stock | 1275 | $67.67 | 92,387.0000 | 20,731,000 | 1.36% | 0.01% |
| Feb. 15, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Mutz Christopher | HEAD OF RARE DISEASE | F | Common Stock | 1261 | $57.55 | 93,662.0000 | 20,731,000 | 1.33% | 0.01% |
| Feb. 14, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Mutz Christopher | HEAD OF RARE DISEASE | A | Common Stock | 18790 | $0.00 | 82,397.0000 | 20,731,000 | 29.54% | 0.09% |
| Feb. 14, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Mutz Christopher | HEAD OF RARE DISEASE | A | Common Stock | 12526 | $0.00 | 94,923.0000 | 20,731,000 | 15.20% | 0.06% |
| Nov. 10, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Mutz Christopher | HEAD OF RARE DISEASE | S | Common Stock | 3000 | $52.47 | 63,607.0000 | 17,644,000 | 4.50% | 0.02% |
| Feb. 28, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Mutz Christopher | HEAD OF RARE DISEASE | A | Common Stock | 11578 | $0.00 | 66,607.0000 | 17,644,000 | 21.04% | 0.07% |
| Feb. 28, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Mutz Christopher | HEAD OF RARE DISEASE | A | Common Stock | 17369 | $0.00 | 55,029.0000 | 17,644,000 | 46.12% | 0.10% |
| March 7, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Mutz Christopher | HEAD OF RARE DISEASE | F | Common Stock | 476 | $44.23 | 37,660.0000 | 17,644,000 | 1.25% | 0.00% |
| March 7, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Mutz Christopher | HEAD OF RARE DISEASE | F | Common Stock | 1426 | $44.23 | 38,136.0000 | 17,644,000 | 3.60% | 0.01% |
| Feb. 15, 2023 | ANI PHARMACEUTICALS INC | $ANIP | Mutz Christopher | HEAD OF RARE DISEASE | F | Common Stock | 1292 | $45.04 | 39,562.0000 | 17,644,000 | 3.16% | 0.01% |